Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1687 (LINC01687)

Target
LINC01687
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1687 (LINC01687) is a long non-coding RNA (lncRNA) from the subclass of intergenic lncRNAs, meaning it is transcribed from regions of the genome that do not contain protein-coding genes. LINC01687 does not encode a protein but may play regulatory roles at the level of chromatin remodeling, gene expression, and transcriptional control as described for the general class of lincRNAs. While the specific function of LINC01687 remains largely uncharacterized, integrative analyses have identified it as a differentially expressed lncRNA in tumor contexts, particularly in lung cancer, and suggest it may serve as a diagnostic biomarker candidate and be of interest in cancer biology. At present, it is not considered a therapeutic target such as a receptor, enzyme, or transporter, but rather a regulatory non-coding RNA with potential relevance to oncology research. There are no reported drugs or established mechanisms of drug action for this lncRNA, nor are there defined safety concerns associated with targeting it. LINC01687 is annotated in gene databases as a human long non-coding RNA gene but does not encode a protein product or correspond to a therapeutic protein target. LINC01687 and other lincRNAs are recognized for their regulatory roles (e.g., regulating neighboring genes, modulating chromatin structure, and transcription), though for most, including this one, detailed functional and disease mechanism studies are still limited. Expression profiling using machine learning and omics datasets has highlighted LINC01687 and other lncRNAs as potential biomarkers for distinguishing cancerous from normal tissues, particularly in lung cancer, but its utility remains at a candidate biomarker stage requiring validation. There is currently no evidence of pharmacological agents targeting LINC01687, and it is not classified as a therapeutic target in the conventional drug development sense.

Other names
LINC01687long intergenic non-protein coding RNA 1687
02

Biological functions

Regulation of gene expressionChromatin remodelingTranscriptional regulationPotential biomarker functionOther
03

Disease associations

Cancer (potential biomarker and role in lung cancer and possibly other cancers)Other
04

Biomarkers

Potential biomarker for cancer (notably lung cancer)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1687 (LINC01687).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1687 (LINC01687).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call